Cooper Laurence James Neil 4
4 · ZIOPHARM ONCOLOGY INC · Filed Jan 2, 2019
Insider Transaction Report
Form 4
Cooper Laurence James Neil
Chief Executive Officer
Transactions
- Tax Payment
Common Stock
2018-12-30$1.66/sh−26,178$43,455→ 1,196,965 total - Tax Payment
Common Stock
2018-12-29$1.66/sh−42,920$71,247→ 1,223,143 total - Tax Payment
Common Stock
2018-12-31$1.87/sh−16,156$30,212→ 1,180,809 total
Footnotes (1)
- [F1]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.